"Biocompatible Materials" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function.
Descriptor ID |
D001672
|
MeSH Number(s) |
D25.130 D27.720.102.130 J01.637.051.130
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Biocompatible Materials".
Below are MeSH descriptors whose meaning is more specific than "Biocompatible Materials".
This graph shows the total number of publications written about "Biocompatible Materials" by people in this website by year, and whether "Biocompatible Materials" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 0 | 1 | 1 |
1997 | 1 | 0 | 1 |
1998 | 0 | 2 | 2 |
1999 | 2 | 1 | 3 |
2000 | 3 | 1 | 4 |
2001 | 0 | 2 | 2 |
2002 | 1 | 4 | 5 |
2003 | 3 | 2 | 5 |
2004 | 0 | 1 | 1 |
2005 | 4 | 8 | 12 |
2006 | 4 | 1 | 5 |
2007 | 6 | 6 | 12 |
2008 | 2 | 6 | 8 |
2009 | 10 | 6 | 16 |
2010 | 4 | 3 | 7 |
2011 | 3 | 5 | 8 |
2012 | 8 | 0 | 8 |
2013 | 2 | 4 | 6 |
2014 | 5 | 3 | 8 |
2015 | 5 | 2 | 7 |
2016 | 4 | 1 | 5 |
2017 | 1 | 2 | 3 |
2018 | 1 | 0 | 1 |
2019 | 2 | 3 | 5 |
2020 | 4 | 3 | 7 |
2021 | 1 | 4 | 5 |
2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biocompatible Materials" by people in Profiles.
-
Influence of Supraphysiologic Biomaterial Stiffness on Ventricular Mechanics and Myocardial Infarct Reinforcement. Acta Biomater. 2022 09 01; 149:30-39.
-
Recent Advances in Designing Electroconductive Biomaterials for Cardiac Tissue Engineering. Adv Healthc Mater. 2022 07; 11(13):e2200055.
-
Immunoengineering strategies to enhance vascularization and tissue regeneration. Adv Drug Deliv Rev. 2022 05; 184:114233.
-
Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials. 2022 01; 280:121297.
-
Biomimetic immunomodulation strategies for effective tissue repair and restoration. Adv Drug Deliv Rev. 2021 12; 179:113913.
-
One-Step Transformation from Rofecoxib to a COX-2 NIR Probe for Human Cancer Tissue/Organoid Targeted Bioimaging. ACS Appl Bio Mater. 2021 03 15; 4(3):2723-2731.
-
An alternative ex vivo method to evaluate the osseointegration of Ti-6Al-4V alloy also combined with collagen. Biomed Mater. 2021 02 18; 16(2):025007.
-
Protein-Functionalized Poly(ethylene glycol) Hydrogels as Scaffolds for Monolayer Organoid Culture. Tissue Eng Part C Methods. 2021 01; 27(1):12-23.
-
Stability Evaluation and Degradation Studies of DAC? Hyaluronic-Polylactide Based Hydrogel by DOSY NMR Spectroscopy. Biomolecules. 2020 10 24; 10(11).
-
Tissue engineering solutions to replace contractile function during pediatric heart surgery. Tissue Cell. 2020 Dec; 67:101452.